# Safety Study of VBY-891 in Healthy Volunteers After Single or Multiple (7 Days) of Oral Dosing (VBY891P1)

> **NCT01947738** · PHASE1 · COMPLETED · sponsor: **Virobay Inc.** · enrollment: 89 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** VBY-891
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01947738
- **Lead sponsor:** Virobay Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 89 (ACTUAL)
- **Last updated:** 2013-12-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01947738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01947738, "Safety Study of VBY-891 in Healthy Volunteers After Single or Multiple (7 Days) of Oral Dosing (VBY891P1)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01947738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*